We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patients With HIV-HCV Co-Infected Subjects on Opioid Substitution Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03549312
Recruitment Status : Unknown
Verified December 2019 by Alexander Wong, MD, Saskatchewan Health Authority - Regina Area.
Recruitment status was:  Recruiting
First Posted : June 8, 2018
Last Update Posted : December 24, 2019
Gilead Sciences
Information provided by (Responsible Party):
Alexander Wong, MD, Saskatchewan Health Authority - Regina Area

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : July 21, 2020
Estimated Study Completion Date : June 22, 2021